Thrombolysis in acute cerebrovascular disease: indications and limitations.
Hacke
W
W
Department of Neurology, Ruprecht-Karls-Universitat Heidelberg, Germany. werner_hacke@med.uni.heidelberg.de
Ringleb
P
P
Stingele
R
R
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator